They fall, you catch. One might be a winner in the long term: 8 pharma stocks with upside potential of over 35%

Given that the headlines are dominated by what is happening at the border, the street may be forgiven for not noting developments that matter to some sectors of the economy. Just recently, the US FDA said in an order that, unlike in the past when its inspections of Indian companies were pre-announced, all inspections would be unannounced going forward. Will this mean increased headaches for Indian companies? Or is there more to this than meets the eye?